Senate Bill 4120
117th Congress(2021-2022)
Childhood Cancer STAR Reauthorization Act
Became Law
Amendments
Became Public Law 117-350 on Jan 5, 2023
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4120
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
checkPassed on December 20, 2022
Status
Passed
Type
Unanimous Consent
Unanimous Consent
A senator may request unanimous consent on the floor to set aside a specified rule of procedure so as to expedite proceedings. If no Senator objects, the Senate permits the action, but if any one senator objects, the request is rejected. Unanimous consent requests with only immediate effects are routinely granted, but ones affecting the floor schedule, the conditions of considering a bill or other business, or the rights of other senators, are normally not offered, or a floor leader will object to it, until all senators concerned have had an opportunity to inform the leaders that they find it acceptable.
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S9613-9614)
Summary
Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act
This bill reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.
Amendments (1)
Dec 20, 2022
Agreed to in Senate
1
Sponsorship
Senate Amendment 6584
In the nature of a substitute.
Agreed To
Sort by most recent
01/05/2023
Became Public Law No: 117-350.
01/05/2023
Signed by President.
12/28/2022
Presented to President.
12/22/2022
Motion to reconsider laid on the table Agreed to without objection.
12/22/2022
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H10025-10026)
12/22/2022
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H10025-10026)
12/22/2022
DEBATE - The House proceeded with forty minutes of debate on S. 4120.
12/22/2022
Considered under suspension of the rules. (consideration: CR H10025-10026)
12/22/2022
Mr. Pallone moved to suspend the rules and pass the bill.
12/21/2022
Held at the desk.
12/21/2022
Received in the House.
12/21/2022
Message on Senate action sent to the House.
12/20/2022
Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S9613-9614)
12/20/2022
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S9613-9614)
12/20/2022
Measure laid before Senate by unanimous consent. (consideration: CR S9613-9614)
12/20/2022
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
04/28/2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2221)
04/28/2022
Introduced in Senate
Public Record
Record Updated
Nov 9, 2023 9:43:47 PM